NCT02648815

Brief Summary

This study aims to investigate the natural clinical course, diagnostic possibilities and treatment modalities in moderately severe (MSAP) and severe acute pancreatitis (SAP). The management of severe acute pancreatitis varies with the severity and depends on the type of complication that requires treatment. Although no universally accepted treatment algorithm exists, the step-up approach using close monitoring, percutaneous or endoscopic drainage, followed by minimally invasive video-assisted retroperitoneal debridement has demonstrated to produce superior outcomes to traditional open necrosectomy and may be considered as the reference standard intervention for this disorder.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2010

Longer than P75 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
6 years until next milestone

First Submitted

Initial submission to the registry

December 31, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 7, 2016

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
Last Updated

October 28, 2016

Status Verified

October 1, 2016

Enrollment Period

7.3 years

First QC Date

December 31, 2015

Last Update Submit

October 27, 2016

Conditions

Keywords

Necrotizing pancreatitisSepsisInfectionDrainage

Outcome Measures

Primary Outcomes (1)

  • Number of participants converted to more aggressive treatment

    An average of 1 year

Secondary Outcomes (3)

  • Proportion of patients requiring PCD after initial APD

    An average of 1 year

  • Morbidity and mortality in patients requiring PCD

    An average of 1 year

  • Number of PCD interventions required

    An average of 1 year

Study Arms (2)

Percutaneous catheter drainage group

ACTIVE COMPARATOR

Percutaneous catheter drainage (PCD) of necrotic tissue and pathological collections formed during acute pancreatitis

Procedure: Percutaneous catheter drainage

Abdominal paracentesis evacuation group

ACTIVE COMPARATOR

Abdominal paracentesis drainage (APD) of peritoneal fluid during acute pancreatitis

Procedure: Abdominal paracentesis evacuation

Interventions

Depending on the operator experience, tandem trocar technique or Seldinger technique can be used. If the Seldinger technique is used, then the catheter tract should be sequentially dilated over a guidewire. Access routes that avoid crossing the bowel and other intervening organs, or major mesenteric, peripancreatic, or retroperitoneal blood vessels are selected to minimize the risk of bacterial contamination and hemorrhage. Successful percutaneous treatment of necrotic collections of the pancreas depends on several important factors. Catheters often need to remain in place for several weeks and sometimes months; hence, close follow-up is required.

Percutaneous catheter drainage group

Evacuation of peritoneal ascitic fluid using percutaneous catheters

Abdominal paracentesis evacuation group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • fluid collections within two weeks of disease onset;
  • single- or multi-organ failure;
  • CTSI \> = 7 (initial CT performed within 7 days after the onset of disease.); and (4) acute physiology and chronic health evaluation (APACHE) II score \> = 8.

You may not qualify if:

  • patients without APD interventions;
  • patients who underwent necrosectomy directly after APD without PCD as a bridge therapy;
  • previous percutaneous drainage or surgical necrosectomy during the episode of pancreatitis;
  • previous exploratory laparotomy for acute abdomen and intraoperative diagnosis of AP.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Zerem E. Treatment of severe acute pancreatitis and its complications. World J Gastroenterol. 2014 Oct 14;20(38):13879-92. doi: 10.3748/wjg.v20.i38.13879.

  • Zerem E, Imamovic G, Susic A, Haracic B. Step-up approach to infected necrotising pancreatitis: a 20-year experience of percutaneous drainage in a single centre. Dig Liver Dis. 2011 Jun;43(6):478-83. doi: 10.1016/j.dld.2011.02.020. Epub 2011 Apr 8.

  • Zerem E, Imamovic G, Omerovic S, Imsirovic B. Randomized controlled trial on sterile fluid collections management in acute pancreatitis: should they be removed? Surg Endosc. 2009 Dec;23(12):2770-7. doi: 10.1007/s00464-009-0487-2. Epub 2009 May 15.

MeSH Terms

Conditions

PancreatitisPancreatitis, Acute NecrotizingSepsisInfections

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Enver Zerem, MD.PhD

    University Clinical Center Tuzla

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of medicine

Study Record Dates

First Submitted

December 31, 2015

First Posted

January 7, 2016

Study Start

January 1, 2010

Primary Completion

April 1, 2017

Study Completion

July 1, 2017

Last Updated

October 28, 2016

Record last verified: 2016-10